New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 29, 2012
16:27 EDTJOSB, WLP, ARQL, YELP, DY, COn The Fly: Closing Wrap
Stocks on Wall Street were slightly higher as the Fed's Beige Book and reports on second quarter economic growth and July pending home sales were all encouraging. Stock futures were generally quiet in premarket trading but rose a bit after the GDP revision, leading to a slightly higher open for the broader market. The averages moved in a very narrow range for much of the day before solidifying in positive territory after the Beige Book said that moderate expansion in the economy had continued since the last report. A late day fade dented the gains, but the averages hung on to post modest increases... ECONOMIC EVENTS: The Federal Reserve's Beige Book, its anecdotal account of the state of the economy, stated that economic activity in nine of the Fed's 12 districts rebounded. The U.S.'s second estimate of Q2 GDP growth was revised up to 1.7% from 1.5%, as expected, and Q2 personal consumption growth was revised upward to 1.7% from a prior 1.5% estimate as well. Pending home sales grew 2.4% on a month-over-month basis in July, which was ahead of forecasts... COMPANY NEWS: WellPoint (WLP) rose $4.41, or 7.68%, to $61.80 as investors responded favorably to the decision of its CEO, Angela Braly, to submit to shareholder pressure and resign... Citigroup (C) agreed to pay $590M to settle a shareholder lawsuit that claimed it misled investors about the bank's growing problems before the financial crisis... MAJOR MOVERS: Among the notable gainers were Yelp (YELP), up $4.11, or 22.51%, to $22.37, with the move attributed to a short squeeze after an IPO lockup period expired, and JoS. A Bank (JOSB), up $5.81, or 13.96%, to $47.44, after its earnings and revenues beat expectations. Noteworthy losers included Dycom (DY), down $3.60, or 19.07%, to $15.28, and ArQule (ARQL), down $1.24, or 18.51%, to $5.46, following their earnings reports... INDICES: The Dow gained 4.49, or 0.03%, to 13,107.48; the Nasdaq rose 4.05, or 0.13%, to 3,081.19; and the S&P 500 advanced 1.19, or 0.08%, to 1,410.49.
News For WLP;C;YELP;JOSB;DY;ARQL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
November 24, 2015
15:05 EDTCFed to provide means for banks examiners to express divergent views
Subscribe for More Information
10:06 EDTDYHigh option volume stocks
High option volume stocks: BDBD UNXL NVS SEDG BLOX GPRE SIG BPL TIF DY
November 23, 2015
20:08 EDTDYOn The Fly: After Hours Movers
UP AFTER EARNINGS: Copart (CPRT), up 4.9%... Dycom (DY), up 4.6%... Palo Alto Networks (PANW), up 3.9%... Baozun (BZUN), up 6.7%. ALSO HIGHER: Xerox (XRX), up 6.7% after Carl Icahn reported a 7.13% stake in the company... Valeant (VRX), up 3.7% after Pershing Square increases stake in Valeant Pharmaceuticals to 9.9%. DOWN AFTER EARNINGS: Brocade (BRCD), down 5.5%... Ceres (CERE), down 10.3%... YY Inc. (YY), down 3.6%. ALSO LOWER: J.M. Smucker (SJM), down marginally after filing to sell 3.86M shares of common stock for holders.
16:23 EDTDYDycom sees Q2 EPS 52c-60c, may not compare to consensus 39c
Subscribe for More Information
16:21 EDTDYDycom reports Q1 EPS $1.24, consensus $1.01
Subscribe for More Information
15:28 EDTDYNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Palo Alto (PANW), consensus 32c... Copart (CPRT), consensus 43c... Brocade (BRCD), consensus 24c... Post Holdings (POST), consensus 29c... YY (YY), consensus 82c... Dycom (DY), consensus $1.01... Cubic (CUB), consensus 96c... Enanta (ENTA), consensus 15c.
November 18, 2015
09:48 EDTYELPYelp rises on unconfirmed takeover speculation
The shares were last at $28.60, up over 3.7% on the session. At that price next resistance is at $28.83 and then at $29.26. The stock is in a shallow rounding bottom pattern, which is bullish for price and has begun to fill the bearish gap down from July of this year. Support is at $27.70.
09:41 EDTYELPYelp November call activity attributed to takeover speculation
Subscribe for More Information
09:40 EDTYELPRumor: Yelp strength attributed to takeover speculation
Subscribe for More Information
08:55 EDTCMorgan Stanley exec sees Q4 not much better than Q3 for banks, DJ reports
Morgan Stanley (MS) Institutional Securities President Colm Kelleher cautioned that fixed-income markets "still seem subdued," according to Dow Jones, citing his comments at an investment conference. Morgan Stanley was among the banks that reported lower revenue from fixed-income, currency and commodities trading during the third quarter and Kelleher said he doesn't think "the fourth quarter is going to be much better," the report noted. Large bank peers to Morgan Stanley include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link
05:42 EDTCStora Enso Oyj appoints Citi as successor depositary bank for ADR program
Citi (C), acting through Citibank N.A., has been appointed by Stora Enso Oyj (SEOAY) as successor depositary bank for its Level 1 American Depositary Receipt, or ADR, program, which trades on the U.S. OTCQX marketplace under the symbol "SEOAY". Stora Enso's underlying ordinary shares are listed and trade on the NASDAQ OMX Helsinki Stock Exchange under symbol "STERV".
November 17, 2015
07:50 EDTCClearing House to hold a conference
Subscribe for More Information
07:35 EDTARQLArQule reports enrollment of first patient in Phase 1 Proteus syndrome trial
ArQule and the National Human Genome Research Institute, or NHGRI, of the National Institutes of Health, or NIH, announced enrollment of the first patient in the phase 1 clinical trial for Proteus syndrome. This trial, with ARQ 092, an orally available, selective pan-AKT inhibitor, marks the first clinical trial in this rare disease. Proteus syndrome is characterized by overgrowth of the skeleton, skin, adipose tissue and central nervous system. Additionally, ArQule received orphan drug designation from the FDA for ARQ 092 in Proteus syndrome. This marks an important regulatory milestone and the first orphan drug designation for this population. Proteus syndrome impacts fewer than one in a million people worldwide.
November 16, 2015
14:06 EDTCCiti reports October credit loss 2.27% vs. 2.29% last month
Subscribe for More Information
11:24 EDTCClearing House to hold a conference
Clearing House Annual Conference is being held in New York on November 16-18.
10:36 EDTYELPYelp management to meet with Sterne Agee CRT
Meeting to be held in San Francisco on November 16 hosted by Sterne Agee CRT.
09:59 EDTCOmega bought Valeant in Q3, sold some SuneEdison
Leon Cooperman's Omega Advisors gave a quarterly update on its stakes in a filing this morning, disclosing its positions as of September 30. NEW STAKES: Pfizer (PFE), Valeant (VRX) Walgreens Boots Alliance (WBA), TerraForm Global (GLBL), Cigna (CI). INCREASED STAKES: Google Class A (GOOGL), Facebook (FB), Delta Air Lines (DAL). DECREASED STAKES: SunEdison (SUNE), Shire (SHPG), Citi (C), KAR Auction (KAR), LyondellBasell (LYB). LIQUIDATED STAKES: McKesson (MCK), 21st Century Fox (FOXA), General Motors (GM), QEP Resources (QEP), eBay (EBAY).
09:07 EDTCCiti completes OneMain sale
Subscribe for More Information
08:38 EDTCSpringleaf downgraded after settlement on acquisition reached at BMO Capital
As noted earlier, BMO Capital downgraded Springleaf to Market Perform from Outperform. The firm noted that it had recommended buying the stock based on its belief that the company's acquisition of OneMain from Citi (C) had a higher probability of closing than was reflected by the shares. The firm downgraded Spingleaf after the company reached a settlement with governments that will enable the deal to close.
05:37 EDTCCiti appointed successor depository bank for Technip ADR program
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use